Related Experiment Video
Updated: Jan 7, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Glucose-dependent insulinotropic polypeptide (GIP) acts as an appetite regulator rather than as a hypoglycemic
Danhong Cheng1, Manjie Sun1, Jinqian Huang1
1College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, Anhui, China; Engineering Technology Research Center of Healthy Aquaculture, Anhui Agricultural University, Hefei 230036, Anhui, China.
Abstract:
In mammals, glucose-dependent insulinotropic polypeptide (GIP) exerts a potent hypoglycemic effect, whereas its role in fish remains controversial. In this study, synthetic grass carp GIP was administered via intraperitoneal injection, and its effects were evaluated over 24 h. GIP significantly elevated blood glucose levels at 0.5 h post-injection compared to the saline control. This hyperglycemia was accompanied by increased hepatic expression of the gluconeogenic genes glucose-6-phosphatase (g6pc) and phosphoenolpyruvate carboxykinase 1 (pck1) and decreased expression of the glycolytic gene pyruvate kinase (pk). Postprandial expression of the gip gene was also significantly upregulated in the foregut at 6 h. Furthermore, GIP administration modulated central appetite regulators within 1 h, increasing expression of the anorexigenic cocaine- and amphetamine-regulated transcript (cart) and decreasing expression of the orexigenic neuropeptide Y (npy) and agouti related neuropeptide (agrp). Collectively, these results indicate that in grass carp, GIP functions primarily as an appetite regulator rather than as a hypoglycemic incretin, highlighting its potential as a target for studies on appetite control in fish.
More Related Videos
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Dipeptidyl Peptidase 4 Inhibitors
Regulation of Food Intake
Oral Hypoglycemic Agents: Glinides